Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Loading
Home›
Research›
People›
Richard Dakers
AddedFeb 15, 2024
UpdatedMay 31, 2026
Richard Dakers

Richard Dakers

Board Member, Svelte Medical Systems

CrunchbaseLinkedIn

Richard Dakers's Career

Svelte Medical Systems
Svelte Medical Systems

New Providence, NJ, US

Board Member· Board

Create your profile now and gain access to exclusive deals and high-potential startups.

aVenture product preview
aVenture product preview
aVenture product preview

Richard Dakers's Career

Svelte Medical Systems
Svelte Medical Systems
Series A$128.4M302007New Providence, NJ, US
Board Member· Board

Leadership at Svelte Medical Systems

Mina SoochMina SoochBoard Member
Bob FischellBob FischellBoard Member
Somu SubramaniamSomu SubramaniamBoard Member
Bob CroceBob CroceBoard Member
Jack DarbyJack DarbyCEO
Bob FlanaganBob FlanaganBoard Member

Similar to Svelte Medical Systems

NovostentNovostentMountain View, CA, USMedical Devices, Stentsest. 2003NovostentMountain View, CA, US · est. 2003

NovoStent Corp: Innovating stent technologies for vascular treatments across the US healthcare sector.

Pre-Seed · $14.4M6
East End MedicalEast End MedicalMiramar, FL, USMedical Devicesest. 2017East End MedicalMiramar, FL, US · est. 2017

East End Medical: Innovating catheter-based cardiac procedures with advanced medical devices.

Seed · $1.4M27
Dalent MedicalDalent MedicalMiami, FL, USMedical Devicesest. 2017Dalent MedicalMiami, FL, US · est. 2017

Dalent Medical: Innovating ENT care with the world's first universal Sinusleeve™ Balloon for better patient outcomes.

Seed · $2.5M30
Trireme MedicalTrireme MedicalPleasanton, CA, USCatheters, Medical Devices, Stentsest. 2005Trireme MedicalPleasanton, CA, US · est. 2005

TriReme Medical, Inc. globally provides advanced coronary and arterial disease treatment devices.

Public · $58.9M75

Richard Dakers's Similar Executives & Operators

Jay Geoffrey WacherJay Geoffrey WacherBoard Member · BukalapakSoemantri BrodjonegoroSoemantri BrodjonegoroBoard Member · BukalapakLau Eng BoonLau Eng BoonBoard Member · BukalapakWILL WEI CHENGWILL WEI CHENGBoard Member · DiDiDhirubhai H. AmbaniDhirubhai H. AmbaniBoard Member · Reliance RetailMason YeoMason YeoBoard Member · KakaoJaeHong ChoiJaeHong ChoiBoard Member · KakaoYun SeokYun SeokBoard Member · Kakao

People Similar to Richard Dakers

Thomas GundersonThomas GundersonBoard Member · TransMedicsDavid W. AndersonDavid W. AndersonBoard Member · Molecular DetectionWilliam DaiWilliam DaiBoard Member · MeditrinaKevin BallingerKevin BallingerBoard Member · Silk Road Medical